Literature DB >> 19324842

Anti-inflammatory and antioxidant effects of SERPINA3K in the retina.

Bin Zhang1, Yang Hu, Jian-xing Ma.   

Abstract

PURPOSE: Previous studies by the authors have shown that retinal levels of SERPINA3K, a serine proteinase inhibitor, are decreased in an animal model with diabetic retinopathy (DR). The purpose of this study was to investigate the function of SERPINA3K and its role in DR.
METHODS: For the oxygen-induced retinopathy (OIR) model, newborn rats were exposed to 75% O(2) from postnatal day (P) 7 to P12. Cultured retinal cells were treated with CoCl(2) or 2% O(2) to induce hypoxia. CM-H2DCFDA was used to determine the intracellular reactive oxygen species (ROS) level. Inflammatory factors were measured using Western blot analysis or ELISA.
RESULTS: Intravitreal injection of SERPINA3K significantly reduced retinal vascular leakage and leukostasis in the OIR model. SERPINA3K also prevented the hypoxia-induced decrease of occludin, a tight junction protein, in the OIR rat retina and in cultured retinal capillary endothelial cells and retinal pigment epithelial cells. Further, SERPINA3K blocked the overexpression of proinflammatory factors, such as VEGF, TNF-alpha, and ICAM-1, in the retina of the OIR model and in cultured retinal cells exposed to hypoxia. VEGF was downregulated by SERPINA3K at the transcriptional level. Knockdown of SERPINA3K by siRNA resulted in the overexpression of VEGF and TNF-alpha in cultured retinal cells. Moreover, SERPINA3K significantly decreased ROS generation and upregulated the expression and activity of manganese superoxide dismutase and glutathione levels, suggesting antioxidant activity.
CONCLUSIONS: SERPINA3K is an endogenous anti-inflammatory factor, and its anti-inflammatory effects may be mediated through antioxidant activity. Decreased retinal levels of SERPINA3K may contribute to retinal inflammation in DR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324842     DOI: 10.1167/iovs.08-2954

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

Review 2.  Wnt pathway antagonists and angiogenesis.

Authors:  Bin Zhang; Jian-Xing Ma
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

Review 3.  The pathogenesis of early retinal changes of diabetic retinopathy.

Authors:  G B Arden; S Sivaprasad
Journal:  Doc Ophthalmol       Date:  2012-02       Impact factor: 2.379

4.  Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family.

Authors:  Bin Zhang; Jose G Abreu; Kevin Zhou; Ying Chen; Yang Hu; Ti Zhou; Xi He; Jian-xing Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

5.  Longitudinal proteomics analysis in the immediate microenvironment of islet allografts during progression of rejection.

Authors:  Oscar Alcazar; Luis F Hernandez; Ernesto S Nakayasu; Paul D Piehowski; Charles Ansong; Midhat H Abdulreda; Peter Buchwald
Journal:  J Proteomics       Date:  2020-05-20       Impact factor: 4.044

6.  Effects of intravitreal bevacizumab (Avastin) on the porcine retina.

Authors:  Ianors Iandiev; Mike Francke; Felix Makarov; Margrit Hollborn; Susann Uhlmann; Antje Wurm; Alexey Savvinov; Leon Kohen; Andreas Reichenbach; Peter Wiedemann; Thomas Pannicke; Andreas Bringmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-16       Impact factor: 3.117

7.  Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway.

Authors:  Bin Zhang; Kevin K Zhou; Jian-xing Ma
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

8.  The potential of nanomedicine therapies to treat neovascular disease in the retina.

Authors:  Krysten M Farjo; Jian-Xing Ma
Journal:  J Angiogenes Res       Date:  2010-10-08

9.  Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes.

Authors:  Akira Mima; Weier Qi; Junko Hiraoka-Yamomoto; Kyoungmin Park; Motonobu Matsumoto; Munehiro Kitada; Qian Li; Koji Mizutani; Edward Yu; Takeshi Shimada; Jongsoon Lee; Steven E Shoelson; Christian Jobin; Christian Rask-Madsen; George L King
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-19       Impact factor: 4.799

10.  CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa.

Authors:  Daniel M Lipinski; Alun R Barnard; Mandeep S Singh; Chris Martin; Edward J Lee; Wayne I L Davies; Robert E MacLaren
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.